Local Institution - 2131 — Boston, Massachusetts

Local Institution - 2131 is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Local Institution - 2131 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Locally Advanced Solid Tumors, Metastatic Solid Tumors.

Sponsors: Turning Point Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - 2131?

Local Institution - 2131 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - 2131 conducted?

Local Institution - 2131 has 1 clinical trials on record, with 1 currently active. Their work covers Locally Advanced Solid Tumors, Metastatic Solid Tumors.

Is Local Institution - 2131 accredited by Crixeo Health?

Local Institution - 2131 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution - 2131?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.